CHESS‐ALARM Score: Can it raise the ALARM accurately?
暂无分享,去创建一个
[1] Xin Li,et al. CHESS‐ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study , 2022, Journal of gastroenterology and hepatology.
[2] V. de Lédinghen,et al. Impact of type 2 diabetes on the accuracy of non-invasive tests of liver fibrosis with resulting clinical implications. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] X. Forns,et al. Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] C. Couto,et al. Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression , 2021, Frontiers in Immunology.
[5] J. Bosch,et al. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. , 2020, The American journal of gastroenterology.
[6] Siddharth Singh,et al. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta‐analysis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] L. V. Van Gaal,et al. Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features , 2015, PloS one.
[8] V. Beral,et al. Separate and joint effects of alcohol and smoking on the risks of cirrhosis and gallbladder disease in middle-aged women. , 2008, American journal of epidemiology.